Yifeng Dai

1.3k total citations · 1 hit paper
41 papers, 920 citations indexed

About

Yifeng Dai is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yifeng Dai has authored 41 papers receiving a total of 920 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 14 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yifeng Dai's work include Acute Myeloid Leukemia Research (21 papers), Heavy Metal Exposure and Toxicity (6 papers) and Birth, Development, and Health (6 papers). Yifeng Dai is often cited by papers focused on Acute Myeloid Leukemia Research (21 papers), Heavy Metal Exposure and Toxicity (6 papers) and Birth, Development, and Health (6 papers). Yifeng Dai collaborates with scholars based in China, Netherlands and United States. Yifeng Dai's co-authors include Xia Huo, Xijin Xu, Zhiheng Cheng, Lin Fu, Jia Zheng, Shuyi Qiu, Lanlan Liu, Jinlong Shi, Yifan Pang and Marijke M. Faas and has published in prestigious journals such as The Science of The Total Environment, The Journal of Physiology and Journal of Hazardous Materials.

In The Last Decade

Yifeng Dai

40 papers receiving 914 citations

Hit Papers

AHL-mediated quorum sensing to regulate bacterial substan... 2022 2026 2023 2024 2022 25 50 75 100

Peers

Yifeng Dai
Ai Gao China
Xu Yang China
Anuradha Mudipalli United States
Tommaso Serchi Luxembourg
Yifeng Dai
Citations per year, relative to Yifeng Dai Yifeng Dai (= 1×) peers Jialiu Wei

Countries citing papers authored by Yifeng Dai

Since Specialization
Citations

This map shows the geographic impact of Yifeng Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yifeng Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yifeng Dai more than expected).

Fields of papers citing papers by Yifeng Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yifeng Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yifeng Dai. The network helps show where Yifeng Dai may publish in the future.

Co-authorship network of co-authors of Yifeng Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yifeng Dai. A scholar is included among the top collaborators of Yifeng Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yifeng Dai. Yifeng Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Guangcan, Tze‐Sing Huang, Yifeng Dai, Xia Huo, & Xijin Xu. (2025). Effects of POPs-induced SIRT6 alteration on intestinal mucosal barrier function: A comprehensive review. Ecotoxicology and Environmental Safety. 289. 117705–117705.
2.
Qiu, J. F., Xia Huo, Yifeng Dai, Yu Huang, & Xijin Xu. (2025). Potential effects of PFAS exposure on trained immunity: From mechanisms to health risks. Ecotoxicology and Environmental Safety. 302. 118757–118757. 1 indexed citations
3.
Dai, Yifeng, Xijin Xu, Xia Huo, Joost H. N. Schuitemaker, & Marijke M. Faas. (2024). Differential effect of lead and cadmium on mitochondrial function and NLRP3 inflammasome activation in human trophoblast. The Journal of Physiology. 7 indexed citations
4.
Dai, Yifeng, Xijin Xu, Xia Huo, Joost H. N. Schuitemaker, & Marijke M. Faas. (2024). Cell type-dependent response to benzo(a)pyrene exposure of human placental cell lines under normoxic, hypoxic, and pro-inflammatory conditions. Ecotoxicology and Environmental Safety. 276. 116287–116287. 1 indexed citations
5.
Qian, Tingting, Longzhen Cui, Yan Liu, et al.. (2020). High expression of chaperonin-containing TCP1 subunit 3 may induce dismal prognosis in multiple myeloma. The Pharmacogenomics Journal. 20(4). 563–573. 14 indexed citations
6.
Dai, Yifeng, et al.. (2019). Alterations in platelet indices link polycyclic aromatic hydrocarbons toxicity to low-grade inflammation in preschool children. Environment International. 131. 105043–105043. 44 indexed citations
7.
Hu, Ning, Yifan Pang, Hongmian Zhao, et al.. (2019). High expression of DOCK2 indicates good prognosis in acute myeloid leukemia. Journal of Cancer. 10(24). 6088–6094. 12 indexed citations
8.
Liu, Yan, Rongjian Lu, Wei Cui, et al.. (2019). High IFITM3 expression predicts adverse prognosis in acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 38–44. 27 indexed citations
9.
Dai, Yifeng, Zhiheng Cheng, Yifan Pang, et al.. (2019). Prognostic value of the FUT family in acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 70–80. 19 indexed citations
10.
Liu, Yan, Zhiheng Cheng, Qihui Li, et al.. (2019). Prognostic significance of the PANK family expression in acute myeloid leukemia. Annals of Translational Medicine. 7(12). 261–261. 14 indexed citations
11.
Cui, Longzhen, Yan Liu, Yifan Pang, et al.. (2019). Emerging agents and regimens for treatment of relapsed and refractory acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 1–14. 20 indexed citations
12.
Cheng, Zhiheng, Lei Zhou, Kai Hu, et al.. (2018). Prognostic significance of microRNA-99a in acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 53(9). 1089–1095. 9 indexed citations
13.
Cheng, Zhiheng, Yifeng Dai, Yifan Pang, et al.. (2018). Clinical and Biological Implications of Mutational Spectrum in Acute Myeloid Leukemia of FAB Subtypes M0 and M1. Cellular Physiology and Biochemistry. 47(5). 1853–1861. 3 indexed citations
14.
Cheng, Zhiheng, Kai Hu, Lei Tian, et al.. (2018). Clinical and biological implications of mutational spectrum in acute myeloid leukemia of FAB subtypes M4 and M5. Cancer Gene Therapy. 25(3-4). 77–83. 11 indexed citations
15.
Cui, Longzhen, Zhiheng Cheng, Yan Liu, et al.. (2018). Overexpression of PDK2 and PDK3 reflects poor prognosis in acute myeloid leukemia. Cancer Gene Therapy. 27(1-2). 15–21. 41 indexed citations
16.
Cheng, Zhiheng, Yifeng Dai, Yifan Pang, et al.. (2018). Enhanced expressions of FHL2 and iASPP predict poor prognosis in acute myeloid leukemia. Cancer Gene Therapy. 26(1-2). 17–25. 19 indexed citations
17.
Dai, Yifeng, Yuan Zhang, Xiufeng Wang, et al.. (2018). Mutational spectrum and prognostic stratification of intermediate-risk acute myeloid leukemia. Cancer Gene Therapy. 25(7-8). 207–213. 5 indexed citations
18.
Li, Minghui, et al.. (2017). Proteomic evaluation of human umbilical cord tissue exposed to polybrominated diphenyl ethers in an e-waste recycling area. Environment International. 111. 362–371. 42 indexed citations
19.
Dai, Yifeng, et al.. (2017). Elevated lead levels and changes in blood morphology and erythrocyte CR1 in preschool children from an e-waste area. The Science of The Total Environment. 592. 51–59. 58 indexed citations
20.
Xu, Xijin, Xiaojuan Chen, Jian Zhang, et al.. (2015). Decreased blood hepatitis B surface antibody levels linked to e-waste lead exposure in preschool children. Journal of Hazardous Materials. 298. 122–128. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026